← Concept Vault
Concept · Neuroscience · Maps to the Law of Polarity

GABA & Glutamate

The brain has a gas pedal and a brake, and almost everything you call "a state of mind" is the ratio between them at a given moment.
Read · 21 minPillar · Neuroscience

Most people who learn a little neuroscience anchor on dopamine and serotonin — the "feel-good" molecules, the celebrities. That's a category error of scale. Dopamine and serotonin are modulators: they tune and color the signal. But the signal itself — the raw on/off electrical conversation that is your brain computing — runs on two amino-acid neurotransmitters you rarely hear named in a self-help book: glutamate, which says fire, and GABA, which says don't. The great majority of fast synaptic transmission in your cortex runs through one of these two (glutamate is the dominant excitatory transmitter, GABA the dominant inhibitory one; commonly cited estimates put their combined share of cortical synapses high, though exact figures vary by method and region). Dopamine gets the headlines; glutamate and GABA are doing the actual work of being you.

This is the cleanest case study of the Law of Polarity that biology offers. Not a metaphor for it — a literal, molecular instance. Too far toward excitation and you seize and die. Too far toward inhibition and you sedate, anesthetize, coma, and die. Life — thought, perception, the felt sense of being awake and sane — lives in the narrow, dynamically defended band between two lethal poles. Let's pull it all the way down to the molecule and back up to your experience of being alive.

01

What it is

Glutamate is the principal excitatory neurotransmitter in the central nervous system. When a glutamate molecule binds the right receptor on the receiving neuron, it nudges that neuron toward firing — it depolarizes the membrane, makes an action potential more likely. It is, by a wide margin, the most abundant neurotransmitter in the brain. Almost every fast "yes, pass it on" signal in your cortex and hippocampus is glutamate.

GABA — gamma-aminobutyric acid — is the principal inhibitory neurotransmitter. When GABA binds its receptor, it does the opposite: it makes the receiving neuron less likely to fire — it hyperpolarizes the membrane or shunts the incoming current to ground. GABA is the brake.

The two are not independent chemicals manufactured by separate systems. They are a metabolic loop. GABA is synthesized directly from glutamate by an enzyme called glutamic acid decarboxylase (GAD), which simply lops a carboxyl group off glutamate. So the brake is literally made from the gas pedal. This is worth sitting with: the inhibitory transmitter is a chemical derivative of the excitatory one. Polarity again — the two opposites are the same substance at different points of a single conversion. (Glutamate has a further twist: it doubles as a metabolic fuel and as the backbone of cellular protein synthesis. The brain uses its most dangerous excitatory molecule as a building block, which is exactly why it has to control it so obsessively.)

The phrase the field uses for the relationship between these two is excitation/inhibition balance, almost always shortened to E/I balance. It is one of the most load-bearing concepts in modern neuroscience, and once you have it, a startling amount of psychiatry, pharmacology, and lived experience reorganizes around it.

02

What it does

At the level of a single synapse, the job is trivially simple to state. Glutamate released into the synaptic cleft pushes the next neuron toward threshold. GABA pushes it away. The neuron is constantly summing thousands of these inputs — a flood of "fire" and "don't" arriving simultaneously across its dendrites — and it fires only when the running total of excitation outpaces inhibition by enough to cross threshold. Every neuron is a tiny, continuous polarity referendum.

Now scale that up. The brain is not a network where neurons sit quietly until told to act. It is a system idling at high excitation all the time, with inhibition doing the precise, sculpting work of deciding which of the firing is allowed to mean something. This is the single most counterintuitive and important fact about GABA: inhibition is not the absence of activity. Inhibition is computation. It is what gives the brain edges, contrast, timing, and selectivity.

Three concrete things inhibition does that you feel directly:

  • It carves signal out of noise. In vision, a bright spot gets sharper because GABA neurons suppress the cells around it — lateral inhibition. The same architecture lets you hold one thought while suppressing twenty competing ones. Attention is, mechanistically, the inhibition of everything you're not attending to. Focus is a brake job.
  • It sets the brain's rhythms. Brainwave bands — especially gamma — are produced largely by fast-spiking (often parvalbumin-expressing) GABA interneurons firing in synchronized volleys that periodically silence populations of excitatory cells; gamma rhythms (~30–80 Hz, often centered near 40 Hz) arise from this push-pull between pyramidal cells and interneurons. Gamma is associated with attention and conscious perception, and the "gamma binds perception into a unified moment" idea is an influential but still-debated hypothesis, not a settled fact. Mechanistically, though, the rhythm itself is largely a GABA metronome clocking glutamatergic neurons.
  • It builds the wall against runaway feedback. Excitatory neurons connect to each other. Left unchecked, that's a positive feedback loop — A fires B fires C fires A — that recruits the entire network into a single synchronous, meaningless discharge. That discharge has a clinical name. It's a seizure. GABA is the only thing standing between you and one, continuously, your whole life.

That's the deep frame: the brain is a barely-contained chain reaction, and being sane is the ongoing, moment-to-moment work of inhibition keeping the reaction from going critical while still letting it burn hot enough to think.

03

The mechanism

To work with this — pharmacologically or conceptually — you have to know that glutamate and GABA each act through families of receptors, and the families behave very differently in time. This is where the real machinery lives.

Glutamate receptors split into two great classes. The fast, ionotropic ones are ion channels that open directly when glutamate binds — and the metabotropic ones, which are slower G-protein signals, we'll set aside. The two ionotropic ones that matter for everything below:

  • AMPA receptors are the workhorses of fast excitation. Glutamate binds, the channel snaps open in under a millisecond, sodium rushes in, the neuron depolarizes. Done. This is the brain's everyday "send the signal" channel — millions of these firings per second underlie ordinary perception and thought.
  • NMDA receptors are the strange, brilliant ones. An NMDA receptor is a coincidence detector. At rest its channel is physically plugged by a magnesium ion. Glutamate binding alone won't open it — the neuron also has to already be depolarized (usually by AMPA receptors next door having fired first) to expel the magnesium plug. Only when glutamate is present AND the cell is already active does the NMDA channel open — and when it does, it lets in calcium, which is not just a charge carrier but a second messenger that triggers lasting molecular change inside the cell.

That "AND" gate is one of the most important discoveries in neuroscience, because it is the molecular basis of learning. The NMDA receptor only opens when the input (glutamate) and the cell's own activity coincide — which is the cellular implementation of the learning principle Donald Hebb proposed in 1949 (in The Organization of Behavior), before anyone knew the mechanism: when cell A repeatedly takes part in firing cell B, the connection between them strengthens. (The popular four-word slogan for this, "neurons that fire together, wire together," came later — it was coined by neuroscientist Carla Shatz in 1992, not by Hebb himself.) The calcium that floods in through an open NMDA receptor strengthens that synapse, a process called long-term potentiation (LTP) — first demonstrated by Tim Bliss and Terje Lømo in the rabbit hippocampus in 1973. LTP is, as far as we can tell, a major substrate of memory itself. So glutamate doesn't just carry signals; through the NMDA receptor it changes the wiring based on what fired together. The excitatory system is also the learning system. Hold that — it will matter when we get to ketamine.

GABA receptors split into two as well:

  • GABA-A receptors are fast ionotropic channels. When GABA binds, the channel opens and chloride flows in, hyperpolarizing the cell — pushing it away from firing. GABA-A is the fast brake, and — critically for the pharmacology below — it has extra binding sites on it that other molecules can grab to make the brake more effective.
  • GABA-B receptors are slower G-protein-coupled receptors producing a longer, gentler inhibition. (Baclofen, the muscle relaxant, works here. We'll stay focused on GABA-A.)

Here is the molecular crux of half of all psychoactive drugs ever taken: the GABA-A receptor is not just a switch, it's a switch with volume knobs. It has allosteric sites — places where a molecule can bind that don't open the channel themselves but change how strongly GABA opens it when GABA shows up. Benzodiazepines bind one such site. Alcohol, barbiturates, and many general anesthetics act at related sites. Each of these drugs is, at root, doing the same thing: turning up the gain on the brain's master brake. That single shared mechanism explains why they all sedate, why they're all anticonvulsant, why they're all dangerous together, and why they all carry the same withdrawal nightmare. We'll trace each in the next section.

So the full mechanistic picture: a glutamate signal arrives, AMPA receptors fire fast, NMDA receptors gate learning when activity coincides, and a parallel population of GABA neurons fires chloride-driven inhibition that shapes, times, and contains all of it. Push the gain anywhere on this circuit and you change the state of the whole machine.

04

The landmark science

The story of how this was worked out is unusually clean, and the dates matter because they show how recent our real understanding is.

Glutamate as a transmitter was a hard sell. When researchers proposed in the 1950s and 60s that glutamate — a common metabolic amino acid present everywhere in the body — was also the brain's main excitatory neurotransmitter, the idea was resisted precisely because it seemed too mundane. Jeffrey Watkins, working in the UK from the 1960s onward, did much of the foundational pharmacology that nailed it down, and it was Watkins and colleagues who in 1962 first synthesized and characterized NMDA (N-methyl-D-aspartate) as a selective agonist — which is why the receptor carries that synthetic compound's name. The receptor is named after a chemical that was made in a lab to probe it.

GABA's discovery came at the turn of the 1950s, when Eugene Roberts and Sam Frankel (published 1950) — and, independently and around the same time, Jorge Awapara — identified large amounts of GABA in mammalian brain tissue and were initially puzzled by why a metabolic byproduct was so concentrated in the nervous system. It took most of that decade to establish that this "byproduct" was in fact an inhibitory signal in the brain; the case that GABA acts as an inhibitory neurotransmitter built through the later 1950s (e.g., work on crustacean neurons and Ernst Florey's proposals) — a reminder that the most important molecule in a system can hide in plain sight as apparent waste.

LTP — Bliss and Lømo, 1973. The demonstration that brief high-frequency stimulation of a hippocampal pathway produced a lasting increase in synaptic strength gave learning a physical, glutamatergic substrate for the first time. This is arguably the single most important experiment connecting glutamate to memory.

Excitotoxicity — John Olney, 1969. Olney gave high systemic doses of monosodium glutamate (MSG) to infant mice — primarily by subcutaneous injection — and found it destroyed neurons in regions of the developing brain. He coined the term excitotoxicity (and the word "excitotoxin"): the discovery that the brain's essential excitatory transmitter is, in excess, a neuron-killing poison. This was a conceptual earthquake. The same molecule that lets you think, in the wrong amount or wrong place, dissolves the thinker. (Note the honest limit here, because it's been badly distorted: Olney's neurotoxicity was from massive doses delivered systemically into developing animals — it is not evidence that dietary MSG harms healthy adults, whose blood-brain barrier and metabolism handle ordinary dietary glutamate fine. The "MSG headache" panic is a separate, largely unsupported folk belief. The science is about mechanism in excess, not your ramen.)

The benzodiazepine receptor — Squires & Braestrup, and Möhler & Okada, both 1977. Two groups independently demonstrated specific high-affinity binding sites for benzodiazepines in the brain. The implication was profound and a little eerie: your brain has a dedicated receptor site for Valium. That doesn't mean the brain makes Valium — it means benzodiazepines hijack a modulatory site on the GABA-A receptor that exists for the brain's own fine-tuning. The drug fits a lock that was already there.

Ketamine as a rapid antidepressant — Berman et al., 2000, then Zarate et al., 2006. A small, careful Yale study (Berman, Krystal, Charney and colleagues; seven patients with major depression) followed by a landmark NIMH trial in treatment-resistant patients led by Carlos Zarate showed that a single sub-anesthetic intravenous dose of ketamine — an NMDA receptor antagonist, originally an anesthetic and a club drug — relieved severe, treatment-resistant depression within hours, where every existing antidepressant takes weeks. This broke the decades-old monoamine consensus (that depression is fundamentally about serotonin/norepinephrine) and dragged the glutamate system to the center of mood research. It is one of the most important findings in psychiatry this century, and it leads directly to the FDA approval of esketamine (Spravato) in 2019.

05

How it shapes experience

This is where the molecules become things you've actually felt. Every one of the following is E/I balance, lived from the inside.

Alcohol is the clearest tour of the whole system in one substance. Drink, and you push the brain toward inhibition along two axes at once: ethanol potentiates GABA-A receptors (turns up the brake) and blocks NMDA receptors (cuts the excitatory learning channel). Now read your own experience off the mechanism. The early relaxation and lowered anxiety — that's GABA potentiation taking the edge off cortical excitation. The loosening of inhibition and judgment — frontal-lobe brakes going offline. The blackout — that's the NMDA block: with NMDA receptors shut down, LTP can't form, so the night literally doesn't get written to memory. You were conscious and you were not recording, because the molecular machinery of recording was pharmacologically switched off. Slurring, sedation, unconsciousness, and at high enough dose respiratory depression and death — that's just driving the brake further and further down the inhibition pole. Alcohol overdose kills the same way a benzodiazepine overdose does: too much inhibition silences the brainstem circuits that drive breathing.

Now the cruelest twist, and it's pure Polarity: chronic heavy drinking forces the brain to compensate. If GABA is being artificially amplified every night, the brain downregulates GABA and upregulates glutamate to claw E/I balance back to center. Then you stop drinking — and the artificial brake vanishes while the compensatory excitation is still cranked all the way up. The result is a brain catastrophically tipped toward the excitation pole: tremor, racing heart, hallucinations, and delirium tremens — a withdrawal state with a real mortality rate that is, mechanistically, the brain seizing toward the lethal excitatory pole because its brakes were borrowed and got repossessed. This is why you can die from stopping alcohol but not from stopping heroin. Benzodiazepine withdrawal is the same physics and can be just as dangerous.

Benzodiazepines (Valium, Xanax, Ativan, Klonopin) bind that allosteric site on GABA-A and make GABA more effective wherever GABA is already acting. Felt experience: anxiety drops, muscles relax, sleep comes, and — at clinical doses for seizure — the brain's runaway excitation gets clamped. They are superb acute anxiolytics and the frontline drug for stopping active seizures, because anxiety and seizure are both, at root, excess excitation, and the benzo turns up the one brake that opposes it. The honest cost is the same compensation loop as alcohol: the brain adapts, tolerance climbs, and discontinuation can produce rebound anxiety, insomnia, and seizures. The same Polarity logic, the same withdrawal danger.

General anesthesia is, in large part, the deliberate clinical pinning of the brain toward the inhibition pole — many anesthetics potentiate GABA-A (and some block NMDA). The anesthesiologist is titrating you down the inhibition axis far enough to abolish consciousness and memory but not so far that breathing and heartbeat stop. That titration is managing E/I balance with a needle. The fact that consciousness winks out cleanly as you slide toward the inhibitory pole is one of the most direct demonstrations we have that "being awake" is a particular position on this axis, not a fixed property.

Epilepsy is the experience of the excitatory pole winning locally. A seizure is a population of glutamatergic neurons recruiting their neighbors into runaway synchronous firing that inhibition fails to contain. That's why nearly every anticonvulsant drug works by either boosting GABA or damping glutamate/sodium-channel excitation — you treat a seizure by force-feeding the inhibitory pole. And it's why a benzo is what's pushed in an IV to stop a seizure in progress.

Stroke, traumatic brain injury, and ALS all involve excitotoxicity — Olney's poison in action. When neurons are injured or starved of oxygen, they dump glutamate uncontrollably. The flood over-activates NMDA receptors, calcium pours into neighboring cells far beyond the learning-signal range, and that calcium overload triggers cell death — so the initial injury spreads through a chemical chain reaction. Much of the brain damage after a stroke is not the original event but this glutamate-driven aftershock killing cells that survived the first hit. The same molecule that writes your memories, in flood conditions, executes the cells around the wound.

And the everyday version you've felt without naming: the racing, can't-shut-it-off, everything-is-too-loud quality of severe anxiety, overstimulation, or the wired edge of too much coffee and no sleep is the felt signature of E/I balance tipped toward excitation. The heavy, foggy, slowed, can't-find-the-word quality of being sedated, deeply exhausted, or coming up on a benzo is the felt signature of it tipped toward inhibition. You are reading your own E/I ratio off your subjective state all day long.

06

Where it's distorted / oversold

The honest cut. Three places this gets mangled — two by the wellness industry, one by science journalism.

"Boost your GABA" supplements. Walk into any supplement shop and you'll find GABA pills sold for calm and sleep. The problem is a wall: oral GABA does not meaningfully cross the blood-brain barrier in healthy adults. The brain guards its own E/I balance far too carefully to let a swallowed dose of the master brake waltz in from the gut — which, if you think about the seizure/coma stakes, is exactly the safety design you'd want. There is some contested evidence for minor effects, possibly via the enteric nervous system or via a leaky barrier in some people, but the clean claim "take GABA, raise brain GABA, feel calm" is not established and is mostly marketing. (L-theanine and some others have better, though still modest, evidence — but the mechanism story sold on the bottle is usually fiction.) Mark this: contested-to-myth.

The MSG panic. Covered above, but it's the cleanest example of mechanism getting weaponized into folklore. Olney's excitotoxicity is real, established, and important. The leap from "injected glutamate kills neurons in infant mice" to "dietary MSG gives healthy adults brain damage or headaches" is unsupported — controlled double-blind studies have repeatedly failed to reproduce a reliable "MSG symptom complex." The mechanism is real; the dietary scare is myth. Both can be true, and holding them apart is the whole skill.

"Ketamine cures depression" / the chemical-imbalance simplification. Ketamine's rapid antidepressant effect is one of the most important and real findings in modern psychiatry — established. But the popular framing flattens it. First, exactly how it works is still genuinely contested: the simple "it blocks NMDA receptors" story is incomplete, because other NMDA antagonists don't reliably replicate the antidepressant effect. Leading current hypotheses (Ronald Duman's work, among others) point to a downstream cascade — a surge of glutamate, AMPA-receptor activation, a burst of BDNF and rapid synaptogenesis (new synapse growth) in the prefrontal cortex — meaning ketamine may work less by blocking excitation and more by triggering a rebound of structural plasticity. The honest statement is: it works, fast, and we are still arguing about why. Second, the effect is often transient — relief can fade in days to weeks without maintenance, which is why the clinic model involves repeated dosing, and that opens real questions about long-term safety, bladder toxicity at high chronic doses, and abuse potential. "A single shot fixes depression forever" is oversold. "A genuinely novel, fast-acting mechanism that broke the serotonin monopoly and is reshaping the field" is accurate.

And the meta-distortion underneath all three: the seductive idea that any mental state reduces to "too much X, too little Y, just rebalance the chemical." E/I balance is real and powerful, but it is a system property of billions of dynamically interacting synapses that the brain actively defends and regulates — not a thermostat you set with a pill. The molecule matters. The molecule is not the whole story.

07

The debates & frontier

The E/I imbalance theory of autism and schizophrenia. A major, active hypothesis — pushed prominently by Rubenstein and Merzenich (2003) — proposes that some neurodevelopmental and psychiatric conditions involve a shifted E/I ratio (autism often framed as relatively over-excitation or weakened inhibition; some schizophrenia models implicate NMDA receptor hypofunction on inhibitory interneurons). The strongest single clue for the schizophrenia-NMDA link is observational and old: NMDA antagonists like ketamine and PCP, in non-depressed people, produce a state that strikingly mimics schizophrenia — not just hallucinations but the negative and cognitive symptoms that recreational stimulants don't reproduce. That's a genuine mechanistic fingerprint. But "E/I imbalance" as a unifying theory is contested — it's almost certainly too simple, the direction of imbalance differs by region and condition, and it risks being an unfalsifiable catch-all if every disorder gets labeled "an E/I problem." Real signal, premature unification.

Why doesn't every NMDA blocker treat depression? This is the live edge of the ketamine story and a genuine puzzle. If ketamine works because it's an NMDA antagonist, then memantine (a clean NMDA antagonist used in Alzheimer's) should be an antidepressant — and it largely isn't. This is the strongest evidence that the NMDA block is a trigger for something downstream (the glutamate-surge/AMPA/BDNF/synaptogenesis cascade), not the therapeutic event itself. Hydroxynorketamine, a ketamine metabolite that may act with little NMDA blockade at all, is under active study. Unresolved and important.

Tonic vs. phasic inhibition, and the interneuron zoo. GABA inhibition isn't one thing. There's phasic inhibition (fast synaptic pulses) and tonic inhibition (a steady background clamp from extrasynaptic GABA-A receptors), and a whole taxonomy of GABA interneuron types (parvalbumin, somatostatin, VIP cells) each wiring into the circuit differently. Frontier work is mapping how these specific cell types set rhythms and gate plasticity — this is where the genuinely new understanding of "inhibition as computation" is being written.

Neurosteroids and the rapid-acting frontier. The 2019 FDA approval of brexanolone (an IV formulation of the natural neurosteroid allopregnanolone) for postpartum depression, and later zuranolone (oral, 2023), opened a new front: these are GABA-A positive allosteric modulators acting at a different site than benzodiazepines, and they're rapid-acting antidepressants working through the inhibitory system — a mirror image of ketamine's glutamatergic route. Two opposite poles of the E/I axis, two novel fast antidepressant mechanisms. That symmetry is a clue we don't fully understand yet.

08

How to work with it

You can't pharmacologically dose your own E/I balance at home, and you shouldn't try — that's the seizure/coma axis. But the framework changes how you read and manage your own states, and there are real, non-prescription levers.

  1. Read your state as a position on the axis, not a verdict. When you're wired, racing, over-reactive, can't-stop-thinking — that's excitation-dominant, and the move is not to think harder about it (more glutamate) but to recruit the brake. When you're foggy, flat, slowed, can't-engage — that's inhibition-dominant or depleted excitation, and the move is gentle activation, not forcing focus. Naming which pole you're on tells you which direction to push.
  1. The brake responds to the body, not to argument. Slow breathing — especially long exhales — shifts you toward parasympathetic, inhibition-favoring states. Sleep is when the brain physically resets E/I balance; chronic sleep deprivation is, in part, an excitation-creep problem (which is why sleep loss looks like anxiety and, at the extreme, lowers seizure threshold). You don't talk yourself out of an over-excited brain. You re-tune the oscillator through physiology.
  1. Respect the compensation loop — it's the whole danger of GABAergic substances. Anything that artificially boosts the brake (alcohol, benzodiazepines, "GABA-ergic" sleep aids used nightly) will be met by the brain downregulating its own GABA and upregulating glutamate. That's why the morning after drinking is anxious (rebound excitation), why nightly drinking wrecks sleep architecture, and why you taper benzodiazepines and alcohol — never stop cold. If you take a daily GABAergic, you are running a debt against the excitatory pole, and the bill comes due on withdrawal.
  1. Treat excitotoxicity as a reason to protect the brain from real insults, not as a reason to fear food. Manage the actual drivers of glutamate flood — protect against head injury, treat sleep apnea (intermittent oxygen drops trigger glutamate release), don't normalize chronic high-stress states. The MSG worry is a decoy; the real excitotoxicity levers are oxygen, sleep, and trauma.
  1. If depression is treatment-resistant, the glutamate route is now real medicine — but it's a clinical, supervised tool. Ketamine/esketamine and the neurosteroids exist because the old serotonin-only model left a lot of people behind. Knowing E/I balance is why these even exist is the point: it tells you the brain has more than one chemical axis of mood, and that a stuck state on one axis might be movable from another. That's a question for a psychiatrist, not a supplement aisle.
09

How It Connects

The Law of Polarity — this is the law made molecular. Polarity says the two extremes of any axis are the same thing in degree, that "opposites" are points on one continuum, and that life happens in the dynamic management of the spectrum rather than at either pole. GABA and glutamate are not two unrelated chemicals — GABA is made from glutamate (the enzyme GAD strips one carboxyl group), so the brake is literally the gas pedal transformed: one substance, two poles. And the lethal symmetry is the law in its purest form: drive the system all the way to excitation and you get seizure and death; drive it all the way to inhibition and you get coma and death; everything you value — thought, perception, consciousness — exists only in the contested middle. You don't pick a pole and stay there. Mastery is the continuous, active titration between them, which is precisely what Polarity, correctly understood, demands. · Vibration — neural oscillations (gamma, beta, alpha) are set largely by GABA interneurons clocking glutamatergic firing; the brain's "frequencies" are an E/I rhythm. · Rhythm — the compensation/withdrawal loop is Polarity playing out over time: push one pole, the system swings back toward the other. · Cause & Effect — excitotoxicity is the unforgiving causal chain: glutamate flood → calcium influx → cell death, no exceptions, no frequency-thinking your way out of it. · Dopamine & the modulatory systems — dopamine and serotonin color the signal; glutamate and GABA are the signal. Related structures/concepts: NMDA and AMPA receptors, long-term potentiation (LTP) and Hebbian plasticity, the blood-brain barrier, neuroplasticity, and the monoamine hypothesis of depression that the ketamine findings cracked open.

The Compression

The brain is a chain reaction held one notch below critical. Glutamate is the fire; GABA is the only thing keeping the fire from becoming an explosion or going out — and being awake, sane, and yourself is the narrow live band between the two poles, defended every millisecond.

Your Practice
My Depth
My Notes
← Previous
Cortisol & the Stress Response
Next →
Acetylcholine